Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1[ozanimod cloridrato]1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
2[Ozanimod]1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
3[RPC1063 equiv to ozanimod HCI]1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬
4[RPC1063 equiv. to ozanimod HCI]1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬
5Other: Glatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod7件: Acetate,
Fingolimod,
Glatiramer,
Ozanimod (Ozanimodum),
Ponesimod,
Siponimod,
Teriflunomide		10件: Fingolimod hydrochloride ,
Glatiramer acetate ,
Fingolimod ,
Teriflunomide ,
Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod),
Siponimod fumarate ,
Ponesimod ,
Siponimod ,
Fingolimod lauryl sulfate 💬 		26件: DHODH,
HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		37件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Efferocytosis, Endocytosis, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagocytosis, Pyrimidine metabolism, Rheumatoid arthritis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
6Ozanimod1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 96, 97 💬
7Ozanimod 0.5 mg1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
8Ozanimod 1 mg1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
9Ozanimod Cloridrato1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
10Ozanimod HCI1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
11Ozanimod HCL1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 96, 97 💬
12Ozanimod hydrochloride1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 96, 97 💬
13Ozanimod Oral Capsule1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 97 💬
14RPC1063 (equivalent to ozanimod1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬
15RPC1063 (equivalent to ozanimod HCl)1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 96 💬
16Select DMTs other than ozanimod1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
17ZEPIOSA® (Ozanimod)1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 97 💬
18ZEPOSIA® (ozanimod)1件: Ozanimod (Ozanimodum)2件: Ozanimod hydrochloride (Ozanimod hydrochloride),
Ozanimod (Ozanimod) 💬 		5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 97 💬